Chemical Reviews, Vol.99, No.9, 2499-2510, 1999
Why does cisplatin reach guanine-N7 with competing S-donor ligands available in the cell?
Keywords:ANTICANCER DRUG CISPLATIN;PLATINUM(II) ANTITUMOR COMPLEXES;MODULATING AGENT WR2721;BOUND L-METHIONINE;SODIUMTHIOSULFATE;TYPES NO3 ;GUANOSINE 5＇-MONOPHOSPHATE;SPECTROSCOPIC PROPERTIES;SELECTIVE PROTECTION;CATIONIC COMPLEXES